CONTINUOUS INFUSION OF HIGH-DOSE CISPLATIN IN CHILDREN - PHARMACOKINETICS OF FREE AND TOTAL PLATINUM

被引:19
作者
BUESCHARBIT, M
GENTET, JC
BERNARD, JL
BREANT, V
CANO, JP
RAYBAUD, C
机构
[1] HOP ENFANTS TIMONE,SERV ONCOL PEDIAT,27 BLVD JEAN MOULIN,F-13385 MARSEILLE 5,FRANCE
[2] UNIV MARSEILLE HOSP,FAC PHARM,PHARMACOCINET LAB,U278,F-13385 MARSEILLE 5,FRANCE
来源
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY | 1987年 / 23卷 / 11期
关键词
D O I
10.1016/0277-5379(87)90444-5
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:1649 / 1652
页数:4
相关论文
共 17 条
[1]  
BUESCHARBIT M, 1982, CANCER CHEMOTHER P S, V9, P8
[2]   Platinum Determination in Plasma and Urine by Flameless Atomic Absorption Spectrophotometry [J].
Cano, J. P. ;
Catalin, J. ;
Bues-Charbit, M. .
JOURNAL OF APPLIED TOXICOLOGY, 1982, 2 (01) :33-38
[3]   CLINICAL-PHARMACOLOGY OF HIGH-DOSE CISPLATIN [J].
CORDEN, BJ ;
FINE, RL ;
OZOLS, RF ;
COLLINS, JM .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1985, 14 (01) :38-41
[4]   CISPLATIN METABOLITES IN PLASMA, A STUDY OF THEIR PHARMACOKINETICS AND IMPORTANCE IN THE NEPHROTOXIC AND ANTITUMOUR ACTIVITY OF CISPLATIN [J].
DALEYYATES, PT ;
MCBRIEN, DCH .
BIOCHEMICAL PHARMACOLOGY, 1984, 33 (19) :3063-3070
[5]   THE INHIBITION OF RENAL ATPASE BY CISPLATIN AND SOME BIOTRANSFORMATION PRODUCTS [J].
DALEYYATES, PT ;
MCBRIEN, DCH .
CHEMICO-BIOLOGICAL INTERACTIONS, 1982, 40 (03) :325-334
[6]  
DEGREGORIO MW, 1985, CANCER CHEMOTH PHARM, V15, P183
[7]  
DREWINKO B, 1973, CANCER RES, V33, P3091
[8]  
EARHART RH, 1983, CANCER RES, V43, P1187
[9]   EFFECT OF MANNITOL AND PLASMA ON THE CYTO-TOXICITY OF CISPLATIN [J].
HOLDENER, EE ;
PARK, CH ;
BELT, RJ ;
STEPHENS, RL ;
HOOGSTRATEN, B .
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1983, 19 (04) :515-518
[10]  
LOKICH JJ, 1980, CANCER TREAT REP, V64, P905